Updates Therapy for Covid-19 Patients in Pregnant and Lactating Women Review Journal

ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes disease 2019 (Covid-19). On January 30, 2020 WHO declared Covid-19 a Public Health Emergency of international concern, and caused millions deaths worldwide. COVID-19 infection can increase in patients who are pregnant. Changes immune system physiology pregnant women risk complications from infection. Pregnancy compromise potentially SARS-CoV-2 pneumonia compared to non-pregnant women. Pregnant often excluded trials because toxicity or side effects, resulting lack knowledge about drug use care during pregnancy. Great uncertainty therapy due appropriate treatment information along with increasing development changes covid19 guidelines. this review aims gather existing on currently available treatments for lactating women, produce an analysis drugs acceptable safety profiles COVID-19. This article series uses Mendeley, Google Scholar, ScienceDirect, PubMed NCBI database October - December 2022. Variables associated incidence under-five malnutrition were maternal nutrition (p= 0,000; OR = 17,000), parenting feeding patterns 0,003; 13,500), family income 0,002; 12,000), while availability clean water 0.449; 2.429) was found unrelated malnutrition. In conclusion, not related malnutrition, other three variables studied related. So, prevent it necessary mothers take active action seeking nutritious food, cultivating local food supply keep clean. Further research needs develop examined by researchers, namely history low birth weight babies. Researchers hope foods, utilizing so they able serve healthy families, especially toddlers. addition, treating drinking properly does become source spreading Keywords: Toddlers, Malnutrition, Income, Knowledge Nutrition, Parenting ABSTRAK merupakan yang berperan atas penyakit Pada tanggal 30 Januari menetapkan sebagai menjadi perhatian Internasional, dan menyebabkan jutaan kematian di seluruh dunia. Infeksi dapat meningkat pada pasien dengan kondisi hamil. Perubahan sistem imun fisiologi wanita hamil meningkatkan risiko komplikasi infeksi Kehamilan membahayakan kekebalan tubuh berpotensi dibandingkan tidak Wanita sering dikeluarkan dari uji coba karena terdapat toksisitas atau efek samping, mengakibatkan kurangnya pengetahuan tentang penggunaan obat perawatan selama kehamilan. Ketidakpastian terapi besar informasi pengobatan tepat seiring meningkatknya perkembangan perubahan pedoman covid19. Kajian ini bertujuan untuk mengumpulkan ada tersedia saat menyusui, menghasilkan analisis obat-obatan profil keamanan diterima dalam menyusui Suran artikel menggunakan Oktober Desember A search using 2022 Administration nursing exposed must be seriously considered. Some therapies recommended harm fetus. Safe given COVID 19, vitamin c, d, paracetamol, nac, azithromycin, ramdesivir, dexamethasone, enoxaparine, UFH, vaccines require special attention close monitoring. Every woman has right have safe positive experience, including if confirmed contracted 19 not. more susceptible number infectious diseases, Covid-19. infected at experiencing high levels severity, requiring ventilators intensive care. their pregnancy puts body state immunosuppression. Immunosuppression reduced capacity system. So increases such as pre-eclampsia, coagulopathy, preterm labor (increased premature birth), miscarriage (neonatal mortality) death. Given importance reducing neonates, important determine profile all real time. provide accurate data expectations according world. The following types presented lactation, without teratogenic effects minimal exposure breastfed infants, Azithromycin, Ramdesivir, Dexamethasone, Enoxaparine, UFH As well additional symptoms arise female COVID-19, Vitamin C, D, Paracetamol, NAC. Regarding vaccination, strongly second third trimesters receive vaccine. administration first dose vaccination begins trimester carried out interval type vaccine (either mRNA viral vector) contain replicating virus, highly exposure. continues undergo vaccination. SARS-CoV-2, Women, Lactating Woman, Pharmacological Treatment